Benzinga | Dec 8, 2021 05:10AM EST

Piper Sandler Upgrades Pulmonx to Overweight, Announces $45 Price Target

Piper Sandler analyst Jason Bednar upgrades Pulmonx (NASDAQ:LUNG) from Neutral to Overweight and announces $45 price target.